{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:43:27Z","timestamp":1784249007813,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014543","name":"Institute for Collaborative Biotechnologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2010\/07699-1"],"award-info":[{"award-number":["2010\/07699-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/19773-5"],"award-info":[{"award-number":["2015\/19773-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/05566-6"],"award-info":[{"award-number":["2018\/05566-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/19813-5"],"award-info":[{"award-number":["2018\/19813-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["142302\/2015-5"],"award-info":[{"award-number":["142302\/2015-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005639","name":"Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["743\/15"],"award-info":[{"award-number":["743\/15"]}],"id":[{"id":"10.13039\/501100005639","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.steroids.2020.108680","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T21:30:44Z","timestamp":1592429444000},"page":"108680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Progesterone decreases ovarian cancer cells migration and invasion"],"prefix":"10.1016","volume":"161","author":[{"given":"Ma\u00edra A.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su\u00e9ly V.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruy G.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2020.108680_b0005","unstructured":"L.C. Junqueira, J. Carneiro, Histologia B\u00e1sica 12 ed., GUANABARA KOOGAN, 2017."},{"issue":"2","key":"10.1016\/j.steroids.2020.108680_b0010","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.steroids.2020.108680_b0015","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1530\/ERC-12-0175","article-title":"Hormone response in ovarian cancer: time to reconsider as a clinical target?","volume":"19","author":"Modugno","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.steroids.2020.108680_b0020","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1677\/ERC-08-0075","article-title":"Epithelial ovarian cancer: testing the 'androgens hypothesis'","volume":"15","author":"Olsen","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.steroids.2020.108680_b0025","doi-asserted-by":"crossref","unstructured":"C. Collaborative Group on Epidemiological Studies of Ovarian, V. Beral, R. Doll, C. Hermon, R. Peto, G. Reeves, Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls, Lancet 371(9609) (2008) 303-14.","DOI":"10.1016\/S0140-6736(08)60167-1"},{"issue":"1","key":"10.1016\/j.steroids.2020.108680_b0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jnci\/94.1.32","article-title":"Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk","volume":"94","author":"Schildkraut","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.steroids.2020.108680_b0035","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JME-14-0252","article-title":"Progesterone action in breast, uterine, and ovarian cancers","volume":"54","author":"Diep","year":"2015","journal-title":"J. Mol. Endocrinol."},{"issue":"4","key":"10.1016\/j.steroids.2020.108680_b0040","first-page":"708","article-title":"A quantitative assessment of oral contraceptive use and risk of ovarian cancer","volume":"80","author":"Hankinson","year":"1992","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.steroids.2020.108680_b0045","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1054\/bjoc.2000.1463","article-title":"Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies","volume":"83","author":"Akahira","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.steroids.2020.108680_b0050","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1349-7006.2002.tb01323.x","article-title":"Differential expression of progesterone receptor isoforms A and B in the normal ovary, and in benign, borderline, and malignant ovarian tumors","volume":"93","author":"Akahira","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.steroids.2020.108680_b0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/1471-2407-12-553","article-title":"Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival","volume":"12","author":"Lenhard","year":"2012","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.steroids.2020.108680_b0060","doi-asserted-by":"crossref","first-page":"E1410","DOI":"10.1152\/ajpendo.00286.2006","article-title":"Progesterone reduces the migration of mast cells toward the chemokine stromal cell-derived factor-1\/CXCL12 with an accompanying decrease in CXCR4 receptors","volume":"292","author":"Belot","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2020.108680_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.25101","article-title":"Progesterone inhibits endothelial cell migration through suppression of the rho activity mediated by cSrc activation","author":"Lee","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.steroids.2020.108680_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2016.02.005","article-title":"Effect of steroid hormones, estrogen and progesterone, on epithelial mesenchymal transition in ovarian cancer development","volume":"158","author":"Jeon","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.steroids.2020.108680_b0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal adhesion kinase: in command and control of cell motility","volume":"6","author":"Mitra","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.steroids.2020.108680_b0080","unstructured":"P. Calabresi, B.A. Chabner, Antineoplastic agents, in: G.G. A, R. TW, N. AS, T. P (Eds.) Pharmacological basis of therapeutics, New York: Pergamon Press, 1990, pp. 1247-8."},{"issue":"3","key":"10.1016\/j.steroids.2020.108680_b0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/gyno.2000.5789","article-title":"Phase II study of mifepristone (RU486) in refractory ovarian cancer","volume":"77","author":"Rocereto","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.steroids.2020.108680_b0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ygyno.2009.10.071","article-title":"A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group study","volume":"116","author":"Rocereto","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.steroids.2020.108680_b0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2407-11-207","article-title":"Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression","volume":"11","author":"Tieszen","year":"2011","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.steroids.2020.108680_b0100","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s10637-011-9655-z","article-title":"Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2","volume":"30","author":"Goyeneche","year":"2012","journal-title":"Invest. New Drugs"},{"issue":"3","key":"10.1016\/j.steroids.2020.108680_b0105","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200211099","article-title":"Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action","volume":"161","author":"Castoria","year":"2003","journal-title":"J. Cell Biol."},{"issue":"32","key":"10.1016\/j.steroids.2020.108680_b0110","doi-asserted-by":"crossref","first-page":"33146","DOI":"10.18632\/oncotarget.5082","article-title":"Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges","volume":"6","author":"McFall","year":"2015","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.steroids.2020.108680_b0115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1158\/1940-6207.CAPR-14-0054","article-title":"Progesterone inhibits endometrial cancer invasiveness by inhibiting the TGF\u03b2 pathway","volume":"7","author":"Bokhari","year":"2014","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.steroids.2020.108680_b0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2018.06.004","article-title":"Activation of membrane progesterone receptor-alpha increases proliferation, migration, and invasion of human glioblastoma cells","volume":"477","author":"Gonz\u00e1lez-Orozco","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"issue":"9","key":"10.1016\/j.steroids.2020.108680_b0125","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1091\/mbc.e12-11-0807","article-title":"Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes","volume":"24","author":"Bellance","year":"2013","journal-title":"Mol. Biol. Cell"},{"issue":"15","key":"10.1016\/j.steroids.2020.108680_b0130","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1073\/pnas.91.15.7179","article-title":"Nuclear localization signals also mediate the outward movement of proteins from the nucleus","volume":"91","author":"Guiochon-Mantel","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9\u201310","key":"10.1016\/j.steroids.2020.108680_b0135","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.steroids.2008.01.010","article-title":"The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression","volume":"73","author":"Boonyaratanakornkit","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2020.108680_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-016-0219-x","article-title":"Progesterone acts via the progesterone receptor to induce adamts proteases in ovarian cancer cells","volume":"9","author":"Lima","year":"2016","journal-title":"J. Ovarian Res."},{"issue":"4","key":"10.1016\/j.steroids.2020.108680_b0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12672-010-0023-9","article-title":"Expression of membrane progesterone receptors (mPR\/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events","volume":"1","author":"Charles","year":"2010","journal-title":"Horm. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.steroids.2020.108680_b0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-0378(98)00020-5","article-title":"Involvement of trophoblast in embryo implantation: regulation by paracrine factors","volume":"39","author":"Bischof","year":"1998","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.steroids.2020.108680_b0155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-3-56","article-title":"Human trophoblast function during the implantation process","volume":"3","author":"Staun-Ram","year":"2005","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"3","key":"10.1016\/j.steroids.2020.108680_b0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9378(98)70420-X","article-title":"Expression of gelatinase B by trophoblast cells: down-regulation by progesterone","volume":"178","author":"Shimonovitz","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.steroids.2020.108680_b0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yexcr.2018.01.017","article-title":"ADAMTS-1 disrupts HGF\/c-MET signaling and HGF-stimulated cellular processes in fibrosarcoma","volume":"363","author":"Noriega-Guerra","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.steroids.2020.108680_b0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1095\/biolreprod.105.044925","article-title":"Difference in progesterone-receptor isoforms ratio between early and late first-trimester human trophoblast is associated with differential cell invasion and matrix metalloproteinase 2 expression","volume":"74","author":"Goldman","year":"2006","journal-title":"Biol. Reprod."},{"issue":"2","key":"10.1016\/j.steroids.2020.108680_b0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1385\/ENDO:21:2:123","article-title":"Dual roles of progesterone in embryo implantation in mouse","volume":"21","author":"Dai","year":"2003","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.steroids.2020.108680_b0180","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1074\/jbc.274.4.2185","article-title":"Progesterone regulates proliferation of endothelial cells","volume":"274","author":"V\u00e1zquez","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.steroids.2020.108680_b0185","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm0997-1005","article-title":"Progesterone inhibits arterial smooth muscle cell proliferation","volume":"3","author":"Lee","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.steroids.2020.108680_b0190","doi-asserted-by":"crossref","unstructured":"M.D. Makoto Saegusa, M.D. Isao Okayasu, Progesterone Therapy for Endometrial Carcinoma Reduces Cell Proliferation but Does Not Alter Apoptosis, American Cancer Society, 1997, pp. 111-120.","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<111::AID-CNCR15>3.0.CO;2-#"},{"key":"10.1016\/j.steroids.2020.108680_b0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.steroids.2015.11.008","article-title":"Progesterone promotes cell migration, invasion and cofilin activation in human astrocytoma cells","volume":"105","author":"Pina-Medina","year":"2016","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.steroids.2020.108680_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030840","article-title":"Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer","volume":"7","author":"van der Horst","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.steroids.2020.108680_b0205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajhg.2018.05.009","article-title":"Natural selection has differentiated the progesterone receptor among human populations","volume":"103","author":"Li","year":"2018","journal-title":"Am. J. Hum. Genet."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X20301069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X20301069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:05:32Z","timestamp":1758535532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X20301069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"alternative-id":["S0039128X20301069"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2020.108680","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progesterone decreases ovarian cancer cells migration and invasion","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2020.108680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108680"}}